Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on March 2nd, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »
Posted on February 3rd, 2017 by Dr. Anton Yuryev in Pharma R&D
Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), Continue reading “Personalized vs. Precision Medicine” »
Posted on August 17th, 2016 by Christine de Vries - Scheidegger in Pharma R&D
“Last year, Vice President Biden said that with a new moonshot, America can cure cancer. Last month, he worked with this Congress to give scientists at the National Institutes of Health the strongest resources that they’ve had in over a decade. So tonight, I’m announcing a new national effort to get it done,” said President Obama in his final State of the Union address in January 2016.